Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KSI: Ketamine for Adolescent Suicidal Ideation
NCT06366334Recruiting
- Sponsor
- Children's Hospital of Eastern Ontario
- Start
- Jan 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in suicidal ideation comparing Ketamine with Placebo (2 arms). Primary endpoint: Proportion of eligible participants who complete the study protocol. Started Jan 2024; status: recruiting.
02
Drugs
ketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT06366334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06366334.